Plus Therapeutics, Inc. Announces Closing of $15 Million Underwritten Public OfferingGlobeNewsWire • 09/26/19
Plus Therapeutics, Inc. Announces Pricing Of $15 Million Underwritten Public OfferingGlobeNewsWire • 09/23/19